Callista Private Equity is specialized on acquisitions of loss-making Group subsidiaries, consolidated non-core affiliated companies and business units facing special situations. The company’s success is based on post transaction restructuring focused on sustainable profitability.
Callista is targeting various industry branches, with a focus on manufacturing, TIMES, services and retail industries. Callista excludes research intensive industries such as pharmaceuticals and biotech from its investment focus.
- DownloadRead more
Callista acquires 100% of the shares of Premier Periclase and RHI Normag from RHI Magnesita Callista Private Equity acquires Premier…